Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

País/Região como assunto
Ano de publicação
Tipo de documento
Assunto da revista
País de afiliação
Intervalo de ano de publicação
1.
Gac Med Mex ; 157(Suppl 1): S1-S35, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-33819260

RESUMO

Hemophilia is a hemorrhagic disorder with a sex-linked inherited pattern, characterized by an inability to amplify coagulation due to a deficiency in coagulation factor VIII (hemophilia A or classic) or factor IX (hemophilia B). Sequencing of the genes involved in hemophilia has provided a description and record of the main mutations, as well as a correlation with the various degrees of severity. Hemorrhagic manifestations are related to levels of circulating factor, mainly affecting the musculoskeletal system and specifically the large joints (knees, ankles, and elbows). This document is a review and consensus of the main genetic aspects of hemophilia, from the inheritance pattern to the concept of women carriers, physiopathology and classification of the disorder, the basic and confirmation studies when hemophilia is suspected, the various treatment regimens based on infusion of the deficient coagulation factor as well as innovative factor-free therapies and recommendations for the management of complications associated with treatment (development of inhibitors and/or transfusion-transmitted infections), or secondary to articular hemorrhagic events (hemophilic arthropathy). Finally, relevant reviews of clinical and treatment aspects of hemorrhagic pathology characterized by acquired deficiency of FVIII secondary to neutralized antibodies named acquired hemophilia.


La hemofilia es un trastorno hemorrágico con patrón de herencia ligado al sexo, caracterizado por una incapacidad en la amplificación de la coagulación ocasionada por la deficiencia del factor VIII (hemofilia A o clásica) o del factor IX (hemofilia B). La secuenciación de los genes involucrados en la hemofilia ha permitido la descripción y registro de las principales mutaciones, así como la correlación con los diversos grados de severidad. Las manifestaciones hemorrágicas se relacionan con los niveles de factor deficiente circulante, afectando principalmente al sistema musculoesquelético y en particular a las grandes articulaciones (rodillas, tobillos y codos). El presente documento hace una revisión y consenso de los principales aspectos genéticos de la hemofilia, desde el patrón de herencia y el concepto de mujeres portadoras, la fisiopatología y clasificación de la enfermedad, los estudios básicos y de confirmación ante la sospecha de hemofilia, y de los diversos esquemas de tratamiento basados en la infusión del factor de coagulación deficiente hasta las terapias innovadoras libres de factor, así como de las recomendaciones para el manejo de las complicaciones asociadas al tratamiento (desarrollo de inhibidores y/o infecciones transmitidas por transfusión) o secundarias a los eventos hemorrágicos a nivel articular (artropatía hemofílica). La parte final del documento revisa los aspectos clínicos y de tratamiento relevantes de una patología hemorragica caracterizada por la deficiencia adquirida del FVIII mediada por anticuerpos neutralizantes denominada hemofilia adquirida.


Assuntos
Hemofilia A , Algoritmos , Hemofilia A/diagnóstico , Hemofilia A/etiologia , Hemofilia A/terapia , México
2.
Gac Med Mex ; 157(Supl 1): S1-S37, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-33588427
3.
López-Arroyo, José L.; Pérez-Zúñiga, Juan M.; Merino-Pasaye, Laura E.; Saavedra-González, Azucena; Alcivar-Cedeño, Luisa María; Álvarez-Vera, José Luis; Anaya-Cuellar, Irene; Arana-Luna, Luara L.; Ávila-Castro, David; Bates-Martín, Ramón A.; Cesarman-Maus, Gabriela; Chávez-Aguilar, Lénica A.; Peña-Celaya, José A. de la; Espitia-Ríos, María E.; Estrada-Domínguez, Patricia; Fermín-Caminero, Denisse; Flores-Patricio, Willy; García Chávez, Jaime; García-Lee, María T.; González-Pérez, María del Carmen; González-Rubio, María del Carmen; González-Villareal, María Guadalupe; Ramírez-Moreno, Fabiola; Hernández-Colin, Ana K.; Hernández-Ruiz, Eleazar; Herrera-Olivares, Wilfrido; Leyto-Cruz, Faustino; Loera-Fragoso, Sergio; Martínez-Ríos, Annel; Miranda-Madrazo, María R.; Morales-Hernández, Alba; Nava-Villegas, Lorena; Orellana-Garibay, Juan J.; Palma-Moreno, Orlando G.; Paredes-Lozano, Eugenia P.; Peña-Alcántara, Paula; Pérez-Lozano, Uendy; Pichardo-Cepín, Yayra M.; Reynoso-Pérez, Ana Carolina; Rodríguez-Serna, Mishel; Rojas-Castillejos, Flavio; Romero-Rodelo, Hilda; Ruíz-Contreras, Josué I.; Segura-García, Adela; Silva-Vera, Karina; Soto-Cisneros, Paulina M.; Tapia-Enríquez, Ana L.; Tavera-Rodríguez, Martha G.; Teomitzi-Sánchez, Óscar; Tepepa-Flores, Fredy; Valencia-Rivas, María D.; Valle-Cárdenas, Teresa; Varela-Constantino, Ana; Javier-Morales, Adrián; Martínez-Ramírez, Mario A.; Tena-Cano, Sergio; Terrazas-Marín, Ricardo; Vilchis-González, Shendel P.; Villela-Peña, Atenas; Mena-Zepeda, Verónica; Alvarado Ibarra, Martha.
Gac. méd. Méx ; Gac. méd. Méx;157(supl.1): S1-S37, feb. 2021. tab, graf
Artigo em Espanhol | LILACS-Express | LILACS | ID: biblio-1375490

RESUMO

resumen está disponible en el texto completo


Abstract Hemophilia is a hemorrhagic disorder with a sex-linked inherited pattern, characterized by an inability to amplify coagulation due to a deficiency in coagulation factor VIII (hemophilia A or classic) or factor IX (hemophilia B). Sequencing of the genes involved in hemophilia has provided a description and record of the main mutations, as well as a correlation with the various degrees of severity. Hemorrhagic manifestations are related to levels of circulating factor, mainly affecting the musculoskeletal system and specifically the large joints (knees, ankles and elbows). This document is a review and consensus of the main genetic aspects of hemophilia, from the inheritance pattern to the concept of women carriers, physiopathology and classification of the disorder, the basic and confirmation studies when hemophilia is suspected, the various treatment regimens based on infusion of the deficient coagulation factor as well as innovative factor-free therapies and recommendations for the management of complications associated with treatment (development of inhibitors and/or transfusion transmitted infections) or secondary to articular hemorrhagic events (hemophilic arthropathy). Finally, relevant reviews of clinical and treatment aspects of hemorrhagic pathology charachterized by acquired deficiency of FVIII secondary to neutralized antibodies named acquired hemophilia.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA